IDOI, HAIR & Today’s Extended Watchlist

IDO Security, Inc. IDOI

IDOI has been on fire of late, doubling in value over the past three trading sessions, with four consecutive green days in a row.

Normally at this point, we would consider taking profits off of the table, however, we feel that there is still potential for added gains here. In instances such as this, when our money has doubled yet strength remains, we are likely to sell half of our position, and play the rest with the house’s money.

BARCHART.com is still currently giving IDOI a 72% Overall Buy Rating

____

Biostem U.S. Corp HAIR

After a recent 597% run from the .06 area to .46, HAIR has consolidated, and been making higher lows off of support in the low .20’s.

Just in the past week, the stock got above the 20 & 50 day moving averages, leading us to believe that another run is in the making.

There are also several indicators on the chart which suggest that HAIR has some real potential for growth (no pun intended!).

____

FDA PLAYS — AMRN, HZNP, TLON

HZNP has appeared in our watchlist recently. Yesterday, the stock was up 7%, and appears as if it may gap up this morning. With the company’s FDA PDUFA date approaching on Friday, we certainly want to keep a close watch over HZNP in the next few sessions.

AMRN’s FDA date is this Thursday, one day prior to HZNP’s. We are watching closely here as well.

TLON’s date is coming up in a couple weeks (08/12/12), so there isn’t as much of a sense of urgency just yet, but we will still be following along as zero-hour approaches.

____

Extended Watchlist:

EGCT, STEM, RENU, IWDM

LBSR, TLON, NGSX, CLSP & Today’s Ext. Watchlist

Liberty Star Uranium & Metals Corp. LBSR

LBSR first appeared in our extended watchlist as a momentum play on July 3rd . When we returned from the holiday, we included it in our newsletter once again. At that time the stock was as low as .028. On Friday, the stock closed at .04.

We’ve pointed out a few key points on the chart in the following video.


____

Talon Therapeutics, Inc. TLON

TLON is the play we mentioned last week with an upcoming FDA Date. The company is set to receive results on August 12th on its leukimia treatment, Marquibo.

____

NeurogesX, Inc. NGSX

NGSX is a bottom bouncer that we included in Wednesday’s newsletter. We are still giving it some time, although we have already seen gains of 10-20% in the two days we’ve covered the play.

____

Callisto Pharmaceuticals, Inc. CLSP

Another one of our selections from Wednesday that is performing well for the short time we have been paying attention. CLSP was as low as .57 following our alert, and managed to close at .70 on Friday. If CLSP breaks through its previous resistance of .72, we could see a could turn to bluesky breakout mode.

____

07/21 $615 AAPL Calls (APPL Earnings Expected 07/24 Could run to $620+ into earnings.)

Recent release of the new iPad into Chinese markets, said to have had major effect on the company’s Q2 earnings.

_____

Extended Watchlist:

GPXM, EGCT,

Get Our FREE Daily Reports!